Mark A Tarnopolsky MD PhD
Neuromuscular Medicine, Neurorehabilitation, Neurodevelopmental Disabilities, Child Neurology
Professor of Pediatrics and Medicine at McMaster University / President and CEO of Exerkine Corporation / Director of Neuromuscular and Neurometabolic Clinic at McMaster University Medical Center
Join to View Full Profile
McMaster University Medical Center(Canada)Rochester, NY 14642
Dr. Tarnopolsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Tarnopolsky, based in Hamilton, Canada, is a muscle disease, neurometabolic and neurogenetic specialist who graduated from the Michael G. DeGroote School of Medicine in 1988. He has authored multiple publications, including studies on aging, gene discovery, myopathy and mitochondrial disease, which have been cited in other scholarly works. His research extends into clinical trials, where he serves as a principal investigator or contact for studies on aging, myopathy, male subfertility, Pompe disease, and myotonic dystrophy.
Education & Training
Michael G. DeGroote School of MedicineClass of 1988
Clinical Trials
- (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups Start of enrollment: 2005 Nov 01
- Older Adult Training Study With Creatine and CLA Start of enrollment: 2003 Aug 01
- A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsCOVID-19-Associated Critical Illness Myopathy with Direct Viral Effects.Dubravka Dodig, Mark A Tarnopolsky, Marta Margeta, Katerina Gordon, Marvin J Fritzler
Annals of Neurology. 2022-04-01 - 23 citationsA biallelic pathogenic variant in the OGDH gene results in a neurological disorder with features of a mitochondrial disease.Zheng Yie Yap, Klaudia Strucinska, Satoshi Matsuzaki, Sukyeong Lee, Yue Si
Journal of Inherited Metabolic Disease. 2021-03-01 - 31 citationsManagement of mitochondrial diabetes in the era of novel therapies.Roseanne O. Yeung, Mohammad Al Jundi, Sriram Gubbi, Maria E. Bompu, Sandra Sirrs
Journal of Diabetes and Its Complications. 2021-01-01
Press Mentions
This Scientist Made a Skin-Care Brand That Mimics the Effects of Exercise on Your Skin—Here’s HowApril 16th, 2021
An Autosomal Dominant Neurological Disorder Caused by De Novo Variants in FAR1 Resulting in Uncontrolled Synthesis of Ether LipidsNovember 26th, 2020
Tips for Diagnosing Metabolic MyopathiesSeptember 17th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
